Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;275(1):62-78.
doi: 10.1111/imr.12504.

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies

Affiliations
Review

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies

Persephone Borrow et al. Immunol Rev. 2017 Jan.

Abstract

Induction of broadly neutralizing antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However, some HIV-infected individuals develop bnAbs after approximately 2-4 years of infection, enabling analysis of features of these antibodies and the immunological environment that enables their induction. Distinct subsets of CD4+ T cells play opposing roles in the regulation of humoral responses: T follicular helper (Tfh) cells support germinal center formation and provide help for affinity maturation and the development of memory B cells and plasma cells, while regulatory CD4+ (Treg) cells including T follicular regulatory (Tfr) cells inhibit the germinal center reaction to limit autoantibody production. BnAbs exhibit high somatic mutation frequencies, long third heavy-chain complementarity determining regions, and/or autoreactivity, suggesting that bnAb generation is likely to be highly dependent on the activity of CD4+ Tfh cells, and may be constrained by host tolerance controls. This review discusses what is known about the immunological environment during HIV-1 infection, in particular alterations in CD4+ Tfh, Treg, and Tfr populations and autoantibody generation, and how this is related to bnAb development, and considers the implications for HIV-1 vaccine design.

Keywords: CD4+ T follicular helper cell; CD4+ T follicular regulatory cell; autoantibody; broadly neutralizing antibody; human immunodeficiency virus; regulatory T cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Factors associated with bnAb development in HIV‐1‐infected individuals. HIV‐1‐infected individuals who make bnAbs have been found to have perturbations of their immune system. In contrast, demographic characteristics have not been found to correlate with bnAb development

References

    1. UNAIDS . Prevention Gap Report. Geneva: World Health Organisation, 2016.
    1. Fauci AS, Marston HD. Ending AIDS—Is an HIV vaccine necessary? N Engl J Med. 2014;370:495–498. - PubMed
    1. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell‐mediated immunity HIV‐1 vaccine (the Step Study): A double‐blind, randomised, placebo‐controlled, test‐of‐concept trial. Lancet. 2008;372:1881–1893. - PMC - PubMed
    1. Gilbert PB, Peterson ML, Follmann D, et al. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV‐1 infection in a phase 3 HIV‐1 preventive vaccine trial. J Infect Dis. 2005;191:666–677. - PubMed
    1. Gray GE, Allen M, Moodie Z, et al. Safety and efficacy of the HVTN 503/Phambili study of a clade‐B‐based HIV‐1 vaccine in South Africa: A double‐blind, randomised, placebo‐controlled test‐of‐concept phase 2b study. Lancet Infect Dis. 2011;11:507–515. - PMC - PubMed

Publication types